Best Agrolife Ltd
Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.
It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]
- Market Cap ₹ 1,502 Cr.
- Current Price ₹ 637
- High / Low ₹ 888 / 454
- Stock P/E 40.7
- Book Value ₹ 320
- Dividend Yield 0.46 %
- ROCE 16.5 %
- ROE 18.1 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.3%
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Part of BSE Allcap BSE SmallCap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
127 | 151 | 905 | 1,211 | 1,746 | 1,873 | 1,716 | |
126 | 154 | 854 | 1,045 | 1,432 | 1,648 | 1,563 | |
Operating Profit | 1 | -2 | 51 | 166 | 314 | 226 | 153 |
OPM % | 0% | -1% | 6% | 14% | 18% | 12% | 9% |
1 | 4 | 7 | 2 | 3 | 3 | 6 | |
Interest | 1 | 2 | 5 | 15 | 39 | 62 | 67 |
Depreciation | 0 | 0 | 3 | 12 | 24 | 33 | 38 |
Profit before tax | 0 | 0 | 51 | 141 | 253 | 134 | 54 |
Tax % | 575% | 100% | 27% | 26% | 24% | 21% | |
-0 | 0 | 37 | 105 | 192 | 106 | 37 | |
EPS in Rs | -0.65 | 0.03 | 16.83 | 44.31 | 81.27 | 44.94 | 15.57 |
Dividend Payout % | 0% | 798% | 12% | 5% | 4% | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 27% |
TTM: | -14% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 42% |
TTM: | -82% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | -20% |
1 Year: | -27% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 32% |
Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 22 | 24 | 24 | 24 | 24 |
Reserves | 46 | 48 | 108 | 306 | 504 | 623 | 732 |
0 | 19 | 33 | 270 | 568 | 637 | 578 | |
63 | 35 | 209 | 384 | 380 | 729 | 1,069 | |
Total Liabilities | 117 | 110 | 372 | 984 | 1,475 | 2,013 | 2,403 |
0 | 0 | 19 | 180 | 203 | 362 | 355 | |
CWIP | 0 | 0 | 4 | 5 | 14 | 15 | 13 |
Investments | 32 | 3 | 0 | 0 | 0 | 0 | 0 |
85 | 107 | 349 | 800 | 1,258 | 1,636 | 2,035 | |
Total Assets | 117 | 110 | 372 | 984 | 1,475 | 2,013 | 2,403 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
-14 | -41 | 13 | -60 | -180 | 36 | |
-34 | 31 | 8 | -15 | -19 | -63 | |
48 | 10 | -11 | 67 | 248 | -1 | |
Net Cash Flow | 0 | -0 | 10 | -8 | 49 | -29 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 85 | 87 | 53 | 77 | 73 | 91 |
Inventory Days | 67 | 199 | 391 | 864 | ||
Days Payable | 72 | 124 | 167 | 521 | ||
Cash Conversion Cycle | 85 | 87 | 48 | 152 | 297 | 434 |
Working Capital Days | 61 | 175 | 43 | 117 | 157 | 162 |
ROCE % | 0% | 41% | 34% | 16% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17h - Company officials attended a roadshow in Mumbai.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17h - Company officials attended a roadshow in Mumbai.
-
Announcement Under Regulation 30 (LODR)-Updates
1d - Company enters MOU with Shanghai E-Tong Chemical Co.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Dec
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Dec
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Oct 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Dec 2023TranscriptNotesPPT
-
Nov 2023TranscriptPPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT REC
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Sep 2020TranscriptNotesPPT
Product Portfolio
The Co has three business activities namely, Technical, Formulation, and Branded Products. [1]
The product profile includes insecticides, pesticides, herbicides, plant-growth regulators (PGR) and biocides. As of Q2FY24, it has licence of 250+ formulations registered with Central Insecticide Board (CIB), PGRs and bio fertilizers. As of FY23, it has 60+ products, 80+ technical licenses, 360+ formulation licenses.Some of its best selling products are DIRON, PYMAX, PYDON, IRMA, etc. [2] It launched key products like RONFEN, AXEMAN, REVEAL, CITIGEN, and VISTARA. [3][4]